A detailed history of Israel Englander (Millennium Management LLC) transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Millennium Management LLC holds 37,814 shares of AVXL stock, worth $294,571. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,814
Previous 21,235 78.07%
Holding current value
$294,571
Previous $108,000 47.22%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.39 - $5.02 $56,202 - $83,226
16,579 Added 78.07%
37,814 $159,000
Q1 2024

May 15, 2024

SELL
$4.55 - $6.75 $22,827 - $33,864
-5,017 Reduced 19.11%
21,235 $108,000
Q4 2023

Feb 14, 2024

SELL
$5.04 - $9.95 $1.12 Million - $2.21 Million
-222,045 Reduced 89.43%
26,252 $244,000
Q2 2023

Aug 14, 2023

BUY
$7.66 - $9.5 $1.3 Million - $1.61 Million
169,649 Added 215.71%
248,297 $2.02 Million
Q1 2023

May 15, 2023

SELL
$8.32 - $11.75 $6.28 Million - $8.87 Million
-754,876 Reduced 90.56%
78,648 $674,000
Q4 2022

Feb 14, 2023

BUY
$7.65 - $14.43 $4.82 Million - $9.09 Million
630,156 Added 309.86%
833,524 $7.72 Million
Q3 2022

Nov 14, 2022

SELL
$8.9 - $12.86 $515,523 - $744,902
-57,924 Reduced 22.17%
203,368 $2.1 Million
Q2 2022

Aug 15, 2022

BUY
$7.31 - $12.84 $1.91 Million - $3.35 Million
261,292 New
261,292 $2.62 Million
Q1 2022

May 16, 2022

SELL
$9.74 - $17.69 $337,276 - $612,569
-34,628 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$16.88 - $23.31 $1.57 Million - $2.16 Million
-92,731 Reduced 72.81%
34,628 $600,000
Q3 2021

Nov 15, 2021

BUY
$16.82 - $25.75 $477,536 - $731,068
28,391 Added 28.69%
127,359 $2.29 Million
Q2 2021

Aug 16, 2021

BUY
$10.16 - $28.86 $1.01 Million - $2.86 Million
98,968 New
98,968 $2.26 Million
Q3 2020

Nov 16, 2020

SELL
$3.8 - $5.0 $39,364 - $51,795
-10,359 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$2.62 - $5.2 $260,121 - $516,271
-99,283 Reduced 90.55%
10,359 $51,000
Q1 2020

May 14, 2020

BUY
$2.38 - $5.81 $210,982 - $515,044
88,648 Added 422.25%
109,642 $345,000
Q4 2019

Feb 14, 2020

BUY
$2.31 - $3.14 $48,496 - $65,921
20,994 New
20,994 $54,000
Q3 2019

Nov 14, 2019

SELL
$2.22 - $3.9 $162,597 - $285,643
-73,242 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$2.75 - $3.7 $65,037 - $87,505
23,650 Added 47.69%
73,242 $247,000
Q1 2019

May 14, 2019

SELL
$1.68 - $3.42 $85,995 - $175,062
-51,188 Reduced 50.79%
49,592 $151,000
Q4 2018

Feb 14, 2019

SELL
$1.25 - $2.75 $585,726 - $1.29 Million
-468,581 Reduced 82.3%
100,780 $157,000
Q3 2018

Nov 14, 2018

SELL
$2.23 - $3.82 $219,309 - $375,677
-98,345 Reduced 14.73%
569,361 $1.55 Million
Q2 2018

Aug 14, 2018

BUY
$2.08 - $4.26 $1.39 Million - $2.84 Million
667,706 New
667,706 $1.75 Million
Q1 2018

May 15, 2018

SELL
$2.32 - $3.44 $104,156 - $154,438
-44,895 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$3.12 - $4.94 $68,312 - $108,161
21,895 Added 95.2%
44,895 $145,000
Q3 2017

Nov 14, 2017

BUY
$3.42 - $4.87 $78,660 - $112,010
23,000
23,000 $95,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $607M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.